Does Rallies show 13F holders for ARDT?

Yes. Rallies tracks hedge fund and 13F ownership data for ARDT, including fund names, share counts, latest tracked quarter, and position changes when available.

Is ARDT research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ARDT. It does not provide personalized investment advice.

ARDT (Ardent Health, Inc.) Stock Analysis - Hedge Fund Holdings

Ardent Health, Inc. (ARDT) is a publicly traded Healthcare sector company. As of May 21, 2026, ARDT trades at $9.45 with a market cap of $1.45B and a P/E ratio of 9.87. ARDT moved -3.57% today. Year to date, ARDT is +5.70%; over the trailing twelve months it is -37.54%. Its 52-week range spans $8.07 to $20.72. Analyst consensus is buy with an average price target of $12.59. Rallies surfaces ARDT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns ARDT stock?

Hedge funds tracked by Rallies that own ARDT include Soros Fund, Orbimed Advisors, Third Point, and Mangrove Partners. The latest tracked quarter is Sep 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Ardent Health, Inc..

ARDT Key Metrics

Key financial metrics for ARDT
Metric	Value
Price	$9.45
Market Cap	$1.45B
P/E Ratio	9.87
EPS	$0.96
Dividend Yield	0.00%
52-Week High	$20.72
52-Week Low	$8.07
Volume	10
Avg Volume	0
Revenue (TTM)	$6.32B
Net Income	$230.13M
Gross Margin	0.00%

Top Hedge Funds Holding ARDT

Soros Fund holds 250.00K shares of ARDT, changed +0.00% as of Sep 30, 2024.
Orbimed Advisors holds 206.00K shares of ARDT, changed +0.00% as of Dec 31, 2024.
Third Point holds 75.00K shares of ARDT, changed +0.00% as of Jun 30, 2025.
Mangrove Partners holds 29.24K shares of ARDT, changed -38.21% as of Mar 31, 2026.

Latest ARDT News

Ardent Health Raises IMPACT Savings Target to $55M After 9% EBITDA Growth — Mar 6, 2026
Ardent Health Posts $6.3B Revenue, Cuts Labor Costs 26% and Builds $700M Cash Cushion — Mar 5, 2026
Ardent Health Lawsuit Spurs 33% Stock Plunge While Analysts See $1.63B Revenue — Mar 4, 2026
Ardent Health Partners with hellocare.ai on Enterprise AI Virtual Physician and Nursing — Feb 25, 2026
Ardent Health Hit With Class Action Over $43M Revenue Cut, $54M Reserve Increase — Jan 16, 2026

Recent ARDT Insider Trades

Webb Robert Thomas bought 10.00K (~$174.70K) on Nov 8, 2024.
Webb Robert Thomas bought 10.00K (~$164.90K) on Nov 8, 2024.

ARDT Analyst Consensus

10 analysts cover ARDT: 0 strong buy, 6 buy, 3 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $12.59.

Common questions about ARDT

Who owns ARDT stock?: Hedge funds tracked by Rallies that own ARDT include Soros Fund, Orbimed Advisors, Third Point, and Mangrove Partners. The latest tracked quarter is Sep 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Ardent Health, Inc..
Does Rallies show 13F holders for ARDT?: Yes. Rallies tracks hedge fund and 13F ownership data for ARDT, including fund names, share counts, latest tracked quarter, and position changes when available.
Is ARDT research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ARDT. It does not provide personalized investment advice.